Non Transfusion Dependent Beta Thalassmia clinical trials

Explore recruiting non transfusion dependent beta thalassmia clinical trials.

Also recruiting in Europe

Non Transfusion Dependent Beta Thalassmia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Improvement of MRI assessed cerebral Perfusion and oxygenation by luspatercept-induced Anemia Correction in non-transfusion dependent Thalassemia

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

Non Transfusion Dependent Beta Thalassmia trials by city

Non Transfusion Dependent Beta Thalassmia in Toronto Non Transfusion Dependent Beta Thalassmia in Vancouver Non Transfusion Dependent Beta Thalassmia in Montreal Non Transfusion Dependent Beta Thalassmia in Calgary Non Transfusion Dependent Beta Thalassmia in Edmonton Non Transfusion Dependent Beta Thalassmia in Ottawa Non Transfusion Dependent Beta Thalassmia in Winnipeg Non Transfusion Dependent Beta Thalassmia in Quebec City Non Transfusion Dependent Beta Thalassmia in Hamilton Non Transfusion Dependent Beta Thalassmia in Kitchener Non Transfusion Dependent Beta Thalassmia in London Non Transfusion Dependent Beta Thalassmia in Halifax Non Transfusion Dependent Beta Thalassmia in New York Non Transfusion Dependent Beta Thalassmia in Los Angeles Non Transfusion Dependent Beta Thalassmia in Chicago Non Transfusion Dependent Beta Thalassmia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease